Next 10 |
home / stock / clzny / clzny news
2024-04-25 12:05:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron International Growth Fund gained 1.35% during the first quarter of 2024, while i...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Clariant AG ADR (CLZNY) is expected to report for Q4 2023
2023-11-02 16:55:22 ET Summary Sales are decreasing as demand for durable goods is declining worldwide, and the recovery will likely be slow. EBITDA margins are currently impacted by currency headwinds and weakening demand. The latest acquisition should drive future growth and...
2023-10-30 21:15:02 ET Clariant AG (CLZNF) Q3 2023 Earnings Conference Call October 30, 2023 10:00 AM ET Company Participants Andreas Schwarzwaelder - Head of Investor Relations Conrad Keijzer - Chief Executive Officer Bill Collins - Chief Financial Officer ...
2023-10-24 02:16:03 ET Summary Revenues remain stagnant as the company has focused more on improved profitability. The company remains profitable despite recent margin volatility. Interest expenses represent a serious problem as the company urgently needs to pay down some debt...
2023-08-28 10:57:19 ET Summary Volumes are declining as customers have high inventories. Profit margins are currently depressed due to current headwinds. The company's headwinds are likely of a temporary nature as they are directly linked to the current macroeconomic landscape...
2023-07-28 23:14:12 ET Clariant AG (CLZNF) Q2 2023 Earnings Conference Call July 28, 2023 10:00 AM ET Company Participants Andreas Schwarzwaelder - Head, Investor Relations Conrad Keijzer - Chief Executive Officer Bill Collins - Chief Financial Officer Conf...
2023-04-23 23:08:00 ET Summary Net sales decreased since 2018 as the company has restructured its operations in order to focus on highly profitable business areas. The company is highly profitable thanks to very high and stable EBITDA margins. The company's debt is very manage...
The following slide deck was published by Clariant AG in conjunction with their 2022 Q3 earnings call. For further details see: Clariant AG 2022 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Clariant AG ADR Company Name:
CLZNY Stock Symbol:
OTCMKTS Market:
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Clariant AG ADR (CLZNY) is expected to report for Q4 2023
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Cla...